LGALS9 and chronic kidney disease: In PMN group, there was a significant decrease in serum galectin-9 levels at stage G1 relative to later CKD stages (G1 vs G3: P< 0.001; G1 vs G2: P = 0.046; G2 vs G3: P = 0.036, Figure 7C).